ArticleHuman vaccines & immunotherapeutics2022

Antibody response to SARS-CoV-2 vaccines among hospitalized patients in China: a case-control study.

Fei-Ping Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.